Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06545253

A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
IRCCS Ospedale San Raffaele · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Aim of the study is to perform a non-invasive multimodal retinal imaging investigation in a cohort of patients affected by USH2A retinitis pigmentosa (USH2A-RP), in order to develop a new diagnostic paradigm to categorize clinically relevant subgroups. All the procedures will be performed according to normal clinical practice. In addition, a novel quantitative profiling of serum microRNAs will be carried out in order to analyze the clinical importance of microRNA biomarkers in the clinical setting of the disease.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTmicroRNAs analysisPatients will undergo routinary ophthalmological examination, multimodal retinal imaging and blood sampling

Timeline

Start date
2024-08-01
Primary completion
2025-02-01
Completion
2027-02-01
First posted
2024-08-09
Last updated
2024-08-09

Source: ClinicalTrials.gov record NCT06545253. Inclusion in this directory is not an endorsement.

A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants (NCT06545253) · Clinical Trials Directory